Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Zr7pNY
via IFTTT